Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 3 contracts
Sources: Exclusive Agency Agreement (Can-Fite BioPharma Ltd.), Exclusive Agency Agreement (Uranium Energy Corp), Exclusive Agency Agreement (Can-Fite BioPharma Ltd.)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 30,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 2 contracts
Sources: Exclusive Agency Agreement (Rexahn Pharmaceuticals, Inc.), Exclusive Agency Agreement (Rexahn Pharmaceuticals, Inc.)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇W▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of the lesser of (a) 1% of the gross proceeds raised in such Offering and (b) $50,000 30,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 2 contracts
Sources: Exclusive Agency Agreement (Tapimmune Inc), Exclusive Agency Agreement (Tapimmune Inc)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇W▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 2 contracts
Sources: Exclusive Agency Agreement (Can-Fite BioPharma Ltd.), Exclusive Agency Agreement (Cyclacel Pharmaceuticals, Inc.)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Sources: Exclusive Agency Agreement (Rexahn Pharmaceuticals, Inc.)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇W▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement). Such reimbursement shall be payable immediately upon the closing of each Offering.
Appears in 1 contract
Sources: Placement Agent Agreement (Skystar Bio-Pharmaceutical Co)
Expense Allowance. Out of the proceeds of each the first Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a $50,000 for non-accountable expense allowance of $50,000 (expenses; plus the additional reimbursable amount payable by the Company pursuant to Paragraph D.3 hereunder; provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a $50,000 for non-accountable expense allowance expenses of $50,000 ▇▇▇▇▇▇▇▇▇▇; plus the additional reimbursable amount payable by the Company pursuant to Paragraph D.3 hereunder (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Sources: Exclusive Agency Agreement (Bellerophon Therapeutics, Inc.)
Expense Allowance. Out of the proceeds of each the initial Closing, the Company also agrees to pay reimburse ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance for its out of pocket expenses up to $50,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Sources: Exclusive Agency Agreement (RXi Pharmaceuticals Corp)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇W▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 25,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 75,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a $25,000 for non-accountable expense allowance of $50,000 expenses (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Sources: Exclusive Agency Agreement (Oramed Pharmaceuticals Inc.)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a $25,000 for non-accountable expense allowance expenses of $50,000 ▇▇▇▇▇▇▇▇▇▇ in connection with the Offering; plus the additional reimbursable amount payable by the Company pursuant to Paragraph D.2 hereunder; (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ (a) a non-accountable expense allowance of $50,000 (30,000; provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement)...
Appears in 1 contract
Sources: Exclusive Agency Agreement (Rexahn Pharmaceuticals, Inc.)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 (30,000; provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Sources: Exclusive Agency Agreement (Rexahn Pharmaceuticals, Inc.)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇R▇▇▇▇▇ a non-accountable expense allowance of equal to $50,000 35,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 75,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇R▇▇▇▇▇ a non-accountable expense allowance of $50,000 125,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ a non-accountable expense allowance of $50,000 60,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇R▇▇▇▇▇ a non-accountable expense allowance of $50,000 (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement).
Appears in 1 contract
Sources: Exclusive Agency Agreement (Eyegate Pharmaceuticals Inc)
Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay ▇▇▇▇▇▇▇▇▇▇ (a) a non-accountable expense allowance of $50,000 (30,000;; provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement)...
Appears in 1 contract
Sources: Exclusive Agency Agreement (Rexahn Pharmaceuticals, Inc.)